Abstract
Periodontitis increases the risk of atherosclerosis. The mechanistic pathways between these conditions are not fully understood. It was hypothesised that periodontitis alters the behaviour of monocytes to accelerate the progression of atherosclerosis.Proteomic analysis of monocytes from individuals with periodontitis was altered compared to controls. Bioinformatic analysis identified IGFBP-6 as a suitable target for investigation. Intracellular IGFBP-6 was decreased in monocytes, macrophages and foam cells, while increased in the plasma of individuals with periodontitis compared to controls. This finding was replicated in monocytes and macrophages in vitro using
P. gingivalis LPS as a proxy for periodontitis. IGFBP-6, secreted within EVs, was not biologically active.
The reduction in intracellular IGFBP-6 protein, or the lack of biologically active IGFBP-6 within EVs secreted by monocytes/macrophages in periodontitis, resulted in increased foam cell formation by reducing the levels of cholesterol efflux protein ABCG1. This occurred in an IGF-independent manner. Reduction of IGFBP-6 in foam cells and macrophages treated with P. gingivalis LPS altered the expression of STAT6, CXCL10, IL-18 and Egr-1. This promoted a proinflammatory response, while restoration of IGFBP-6 protein ameliorated inflammation. Restoration of IGFBP-6 protein inhibited macrophage transmigration, suggesting that a decrease of IGFBP-6 promotes invasion.
Infection of ApoE-/- mice with P. gingivalis resulted in alveolar bone loss, reduced IGFBP-6 protein in plasma, dyslipidaemia, and stiffer brachiocephalic arteries more prone to plaque rupture compared to sham-infected mice. Tectorigenin, an isoflavone that can modulate IGFBP-6 protein, was administered to P. gingivalis-infected mice, resulting in less alveolar bone loss, reduced LDL/VLDL concentration, and elastic brachiocephalic arteries less prone to plaque rupture compared to P. gingivalis-infected mice administered DMSO.
This research indicates that IGFBP-6 alters monocyte/macrophage behaviour in periodontitis, and may contribute to the progression of atherosclerosis. The regulation of IGFBP-6 protein by tectorigenin may provide a novel therapeutic agent in the management of atherosclerosis.
| Date of Award | 13 May 2025 |
|---|---|
| Original language | English |
| Awarding Institution |
|
| Supervisor | Sarah George (Supervisor), Jason L Johnson (Supervisor) & Angela H Nobbs (Supervisor) |
Keywords
- IGFBP-6
- Periodontitis
- Atherosclerosis
- Inflammation
Cite this
- Standard